Fee for Service

Business Model

IDRS extends its services to pharmaceutical organizations on a fee-for-service model. In this model, a contract is signed for drug product development service and project is tracked as per milestones.

Project Overlook

IDRS maintains proven track record in Fee-for-Service projects completed so far. Projects approved and launched in the US market had not received any critical observations from the regulatory agencies on the development aspects.